Business Context and Reporting Period
Company: Novanta Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: November 13, 2025
Event: Regulation FD Disclosure regarding revised financial guidance following a recent equity issuance.
Key Financial Metrics and Guidance
The filing provides updated non-GAAP Adjusted Diluted EPS guidance and confirms existing GAAP revenue and Adjusted EBITDA guidance for the fourth quarter and full year 2025.
| Metric | Period | Updated Guidance | Prior Guidance |
|---|---|---|---|
| Adjusted Diluted EPS (Non-GAAP) | Q4 2025 | $0.84 to $0.91 | $0.87 to $0.93 |
| Adjusted Diluted EPS (Non-GAAP) | Full Year 2025 | $3.21 to $3.28 | $3.24 to $3.30 |
| GAAP Revenue | Q4 2025 | $253 million to $257 million | No Change |
| GAAP Revenue | Full Year 2025 | $975 million to $979 million | No Change |
| Adjusted EBITDA (Non-GAAP) | Q4 2025 | $62 million to $65 million | No Change |
| Adjusted EBITDA (Non-GAAP) | Full Year 2025 | $222 million to $225 million | No Change |
Share Count Impact: The guidance revision reflects a weighted average diluted shares outstanding impact of 2.5 million to 2.6 million shares for Q4 2025 and 0.6 million to 0.7 million shares for the full year 2025. The estimated impact for full year 2026 is between 4.7 million and 5.9 million shares.
Material Changes
- EPS Guidance Reduction: Both Q4 and full-year 2025 Adjusted Diluted EPS guidance ranges were lowered slightly due to share dilution from the recent equity issuance.
- Revenue and EBITDA Stability: There were no changes to the GAAP revenue or Adjusted EBITDA guidance ranges.
- Future Dilution: Management estimates a significant increase in diluted shares outstanding for 2026 (4.7M to 5.9M shares) compared to the 2025 impact.
Outlook, Risks, and Contingencies
Management Commentary: The company explicitly states that the guidance revision is solely to reflect the completion of the recent equity issuance. No other operational changes were cited as drivers for the guidance update.
Non-GAAP Reconciliation: The filing notes that a reconciliation of forward-looking Adjusted EBITDA and Adjusted Diluted EPS to GAAP measures is not provided due to the difficulty in forecasting specific items such as acquisition expenses, purchase price allocations, contingent consideration, restructuring, foreign exchange, and tax impacts.
Risks: Forward-looking statements are subject to risks including economic and political conditions affecting customer capital expenditures and business activities. The company disclaims any obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the terms and closing date of the "recent equity issuance" referenced as the cause for dilution.
- Confirm the exact number of shares issued to validate the 2.5M-2.6M Q4 and 0.6M-0.7M full-year share impact estimates.
- Review the 2026 share count projection (4.7M-5.9M) to understand long-term dilution implications.
- Monitor subsequent filings for the reconciliation of non-GAAP guidance to GAAP measures once historical data becomes available.